Model Number LTF-190-10-3D |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
Pain (1994)
|
Event Date 07/21/2021 |
Event Type
Injury
|
Event Description
|
Olympus reviewed the following literature: "three-dimensional versus two-dimensional laparoscopic myomectomy: a randomized controlled trial." objective: this study aimed to compare the surgical outcomes of three-dimensional (3d) and two-dimensional (2d) laparoscopic myomectomy.Study design.A total of 64 patients with symptomatic uterine fibroids were randomly assigned to either the 3d (n = 32) group or the 2d group (n = 32).The primary outcomes were the operative blood loss and change in hemoglobin levels.The secondary outcome was operative time.Results: there were no differences in the baseline demographics between the two groups.The 3d and 2d groups were not significantly different in terms of operative blood loss (129.5 ± 86.5 ml vs.140.9 ± 89.8 ml, p = 0.412), change in serum hemoglobin levels (1.4 ± 1.6 g/dl vs.1.6 ± 1.6 g/dl, p = 0.553), and operative time (77.4 ± 37.8 min vs.82.4 ± 35.4 min, p = 0.344).Furthermore, no differences were observed between the groups with regard to other surgical outcomes.Conclusion: the 3d imaging system had no additional surgical benefit in laparoscopic myomectomy compared with to the conventional 2d imaging system.One patient in the 3d group experienced severe postoperative pain that required a visit to the emergency room on postoperative day 10, but it was managed conservatively without readmission.
|
|
Manufacturer Narrative
|
The suspect device has not been returned to olympus for evaluation.The investigation is in process.Once the investigation has been completed, a supplemental report will be submitted with device evaluation results.
|
|
Manufacturer Narrative
|
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation.Please see the updates in b3, b5, h6, and h10.The device history record was unable to be reviewed for this device since the serial number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the relationship between the device and the adverse event cannot be confirmed.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.Olympus will continue to monitor field performance for this device.
|
|
Event Description
|
The customer provided additional information on 14apr2022: serial numbers are unknown, there was no relationship between the olympus devices and the adverse events, there was no malfunction during the study, and according to the information, there is no need for a device return.
|
|
Search Alerts/Recalls
|
|